Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth P Merricks

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Thrombosis and Haemostasis : JTH|September 5, 2024
Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor riskPooja Vir, Devi Gunasekera, Batsukh Dorjbal, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2026
Corrigendum to 'Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk' [Journal of Thrombosis and Haemostasis. Volume 22, Issue 12, December 2024, Pages 3415-3430]Pooja Vir, Devi Gunasekera, Batsukh Dorjbal, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape CapacityXiaolei Pei, Wenwei Shao, Allene Xing, et al.
Molecular Therapy. Methods & Clinical Development|August 25, 2018
An Observational Study from Long-Term AAV Re-administration in Two Hemophilia DogsJunjiang Sun, Wenwei Shao, Xiaojing Chen, et al.
Blood|September 30, 2010
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyJonathan D Finn, Margareth C Ozelo, Denise E Sabatino, et al.
Blood|January 9, 2010
Prolonged activity of factor IX as a monomeric Fc fusion proteinRobert T Peters, Susan C Low, George D Kamphaus, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dogLucas Van Gorder, Bhavya S Doshi, Elinor Willis, et al.
Blood|August 23, 2003
Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogsKaren E Russell, Eva H N Olsen, Robin A Raymer, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|August 15, 2018
Mechanical Anisotropy Assessment in Kidney Cortex Using ARFI Peak Displacement: Preclinical Validation and Pilot In Vivo Clinical Results in Kidney AllograftsMd Murad Hossain, Randal K Detwiler, Emily H Chang, et al.
Blood|March 22, 2003
Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by desmopressin (DDAVP)Eva H N Olsen, Arlene S McCain, Elizabeth P Merricks, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Haemostasis : JTH|September 5, 2024
Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor riskPooja Vir, Devi Gunasekera, Batsukh Dorjbal, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2026
Corrigendum to 'Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk' [Journal of Thrombosis and Haemostasis. Volume 22, Issue 12, December 2024, Pages 3415-3430]Pooja Vir, Devi Gunasekera, Batsukh Dorjbal, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape CapacityXiaolei Pei, Wenwei Shao, Allene Xing, et al.
Molecular Therapy. Methods & Clinical Development|August 25, 2018
An Observational Study from Long-Term AAV Re-administration in Two Hemophilia DogsJunjiang Sun, Wenwei Shao, Xiaojing Chen, et al.
Blood|September 30, 2010
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyJonathan D Finn, Margareth C Ozelo, Denise E Sabatino, et al.
Blood|January 9, 2010
Prolonged activity of factor IX as a monomeric Fc fusion proteinRobert T Peters, Susan C Low, George D Kamphaus, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dogLucas Van Gorder, Bhavya S Doshi, Elinor Willis, et al.
Blood|August 23, 2003
Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogsKaren E Russell, Eva H N Olsen, Robin A Raymer, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|August 15, 2018
Mechanical Anisotropy Assessment in Kidney Cortex Using ARFI Peak Displacement: Preclinical Validation and Pilot In Vivo Clinical Results in Kidney AllograftsMd Murad Hossain, Randal K Detwiler, Emily H Chang, et al.
Blood|March 22, 2003
Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by desmopressin (DDAVP)Eva H N Olsen, Arlene S McCain, Elizabeth P Merricks, et al.
Pageof 6